Plain-English translation of NCT06700304 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
The CAN-PRIME study is testing a new brain implant called the N1 Implant, designed for people with severe paralysis who cannot move their arms and legs. A robot called the R1 Robot places tiny threads from the implant directly into the brain, allowing the implant to read brain signals and transmit them wirelessly to external devices. This early feasibility study will determine whether the implant and robot are safe and whether they work as intended.
For people with severe paralysis from spinal cord injury or ALS, there are very few options to regain movement or control of devices. This study aims to explore whether a brain-computer interface can safely bridge the gap between a person's intentions to move and actual control of external devices, potentially restoring some independence.
You likely qualify if…
You likely don't qualify if…
If you qualify, you would undergo surgery to have the N1 Implant placed in your skull by the R1 Robot, which carefully inserts tiny threads into specific areas of your brain. After implantation, you would participate in follow-up visits and training sessions to learn how to use the implant to control external devices. The study involves 6 participants total, and you would be closely monitored for safety and to evaluate how well the implant works over time.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
Canada